SlideShare a Scribd company logo
1 of 17
VIGIFLOW
Presented by :
Mr. Kajale Fulchand Vishwanath
M.Pharm first year 2ñd semester
Guided by:
Ms. Shagufta Farooqui
Assistant professor
Department of Pharmacology
Shri Sharda Bhavan Education Society’s
Nanded Pharmacy College Nanded
Presentation on
Content
• What is VigiFlow
• History
• Creating a new report
• General reporting
• Report information section
• Study information tab
• Advantages
• Disadvantages
• Reference
2
11-07-2022
What is VigiFlow ?
• VigiFlow is a web-based ICSR data management system
• It is complete easy management system of ICSR (individual
Case safety reporting ).
• Vigiflow can be used by any authority or company as a database
for report management and data analysis .
• Vigiflow is not primarily tool of UMC (Uppsala monitoring
center) but the data can be transferred to UMC.
3
10/22/2022
HISTORY:
• Vigiflow was initiated in the year 2001 when swiss medic
required a new pharmacovigilant body.
• Vigiflow was created with name ADR PLOT .
• It was supported with primary reporting facility 7 regional
centre in 4 languages.
• The first reporting was done in year 2003 at Ghana.
4
10/22/2022
CREATING A NEW REPORT:
• Once we load to new report option there are two sub option.
• Standard case:
In standard case, cases with ADR , ADE , side effect , drug
reaction or reaction due to possible drug administration etc.
• Parent child case :
A parent child case is filled when the child is suffering from an
ADE / ADR due to medication taken by parent.
5
10/22/2022
General reporting
• General reporting can be done by regional centre it consists
of various important section to be filled.
• Sender’s information
• In sender information various mandatory section like fillers
name, address, designation, date, time and location.
• Report information
• This contain details about event.
• Name/date of birth/age /age group, weight, gender
6
10/22/2022
• Current/ Past drug therapy
• This contain any drug treatment in the current or past time
section must be Filled with details like
• Drug name
• Indication
• Reaction observed
• Reaction observed
• Reaction list of code reaction causality assessment, onset of
reaction end time of reaction , duration of reaction outcome
of reaction details of any treatment given to counteract the
reaction drug dose.
7
10/22/2022
Drug consumed
• List of drug as treatment for the reaction, Drug name dose
• Assessment given
• Assessment can be either be physically or Therapeutically
• Overview of case
• This is a free text which includes case narrative, Sender’s
comments Sender’s diagnosis (MED DRA or ICD 10).
International Classification of Diseases –Medical Dictionary
for Regulatory Activities
8
10/22/2022
Image.no 1 Reporting of adverse drug reactions in VigiFlow
9
10/22/2022
Report information section
Spontaneous: For adverse events collected from the spontaneous
reporting system the report type
Spontaneous report applies
Study: For adverse event reports collected from studies Report
from study applies
10
10/22/2022
Image no 2 Report information section
Study Information Tab
Study type: select as applicable (e.g. Clinical trials)
Study name: enter as applicable according to study title (e.g. An
international randomized trial of additional treatments for COVID-
19 in hospitalized patients who are all receiving the local standard
of care)
11
10/22/2022
Image no 3 study information tab
Adverse reaction section
Reaction/event : Structure the Reaction/event using the appropriate
MedDRA term.
Use the +Sign to structure multiple reactions e.g. If Lack of
therapeutic efficacy
• Reaction/event as reported by initial reporter: enter the
Reaction/event as described by the initial reporter.
12
10/22/2022
Image no 4 Adverse reaction section
Suspected ingredient
• It is possible to indicate which component of the medicinal
product is the suspect of causing the events according to the
following list
• Active ingredient
• Preservative
• Antioxidant
• Stabilizer
• Colour
• Flavouring agent
• Solvent
• Constituent
• Excess percent
13
10/22/2022
Image no 5 suspected ingredients
• Advantages
• Free text providing complete data entry
• Easy and constant connection between regional and national
servers
• Integrated dictionaries which helps correct coding .
• Disadvantages
• Server of different country might have glitch in uploading.
• Need faster internet server.
14
10/22/2022
Conclusions
• VigiFlow is a web-based ICSR data management system that
is used reporting of adverse drug reactions.
• It is easy and constant connection between regional and
national servers.
10/22/2022 15
Reference
• https://who-umc.org/pv-products/vigiflow
• https://who-umc.org/media/165665/1-introduction-and-basic-
features-of-vigiflow.pdf
• https://www.mdpi.com/1660-4601/19/6/3264/htm
10/22/2022 16
vigiflow .pptx

More Related Content

What's hot

Guidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsGuidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsSachin Kumar
 
Methods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptxMethods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptxPankajKadyan5
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study teamManjuJhakhar
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONAnindya Banerjee
 
Clinical Trial Doc.pptx
Clinical Trial Doc.pptxClinical Trial Doc.pptx
Clinical Trial Doc.pptxAKASHJAIN152187
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESanju Kaladharan
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety PharmacologyPavana K A
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology pptShilpa thakur
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacologyRamavath Aruna
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicologyKhadga Raj
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceJABEEN FATIMA
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology Naveen K L
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)Ramavath Aruna
 
Clinical trials its types and designs
Clinical trials  its types and designsClinical trials  its types and designs
Clinical trials its types and designsDevesh Aggarwal
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies SonaliJain736101
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxRushikeshTidake
 

What's hot (20)

Guidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsGuidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trials
 
Methods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptxMethods and Tools for ADR Reporting.pptx
Methods and Tools for ADR Reporting.pptx
 
Clinical trial study team
Clinical trial study teamClinical trial study team
Clinical trial study team
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
 
Clinical Trial Doc.pptx
Clinical Trial Doc.pptxClinical Trial Doc.pptx
Clinical Trial Doc.pptx
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCE
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology ppt
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology PPT On Female Reproductive Toxicology
PPT On Female Reproductive Toxicology
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)
 
Clinical trials its types and designs
Clinical trials  its types and designsClinical trials  its types and designs
Clinical trials its types and designs
 
Pharmacovigilance program of India
Pharmacovigilance program of IndiaPharmacovigilance program of India
Pharmacovigilance program of India
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
Establishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptxEstablishing Pharmacovigilance Centres In Hospital.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
 

Similar to vigiflow .pptx

Dsur presentation1
Dsur presentation1Dsur presentation1
Dsur presentation1Seema Ahirwar
 
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...MedicReS
 
Patient centered Pharmacovigilance .. .
Patient centered Pharmacovigilance     .. .Patient centered Pharmacovigilance     .. .
Patient centered Pharmacovigilance .. .ClinosolIndia
 
regulatory sk.pptx
regulatory sk.pptxregulatory sk.pptx
regulatory sk.pptxManojKumarr75
 
Pharmacovigilance regulations as per European Union
Pharmacovigilance regulations as per European UnionPharmacovigilance regulations as per European Union
Pharmacovigilance regulations as per European UnionBindu Kshtriya
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safetyAzierta
 
assinment signal.pptx
assinment signal.pptxassinment signal.pptx
assinment signal.pptxVermaG3
 
Pharmacovigilance Overview
Pharmacovigilance OverviewPharmacovigilance Overview
Pharmacovigilance OverviewSivasankaranV
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActPAREXEL International
 
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...Pristyn Research Solutions
 
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...Canadian Organization for Rare Disorders
 
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesGlobal Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesMridula Shukla
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol developmentSACHIN C P
 

Similar to vigiflow .pptx (20)

Dsur presentation1
Dsur presentation1Dsur presentation1
Dsur presentation1
 
NDA.pptx
NDA.pptxNDA.pptx
NDA.pptx
 
NDA.pptx
NDA.pptxNDA.pptx
NDA.pptx
 
Vaishali chadha
Vaishali chadhaVaishali chadha
Vaishali chadha
 
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
 
Patient centered Pharmacovigilance .. .
Patient centered Pharmacovigilance     .. .Patient centered Pharmacovigilance     .. .
Patient centered Pharmacovigilance .. .
 
regulatory sk.pptx
regulatory sk.pptxregulatory sk.pptx
regulatory sk.pptx
 
Phase 3
Phase 3Phase 3
Phase 3
 
Pharmacovigilance regulations as per European Union
Pharmacovigilance regulations as per European UnionPharmacovigilance regulations as per European Union
Pharmacovigilance regulations as per European Union
 
IND.pptx
IND.pptxIND.pptx
IND.pptx
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
 
assinment signal.pptx
assinment signal.pptxassinment signal.pptx
assinment signal.pptx
 
Pms slides
Pms slidesPms slides
Pms slides
 
Pharmacovigilance Overview
Pharmacovigilance OverviewPharmacovigilance Overview
Pharmacovigilance Overview
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures Act
 
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
 
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
 
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and VaccinesGlobal Regulatory Pathways for COVID-19 Therapies and Vaccines
Global Regulatory Pathways for COVID-19 Therapies and Vaccines
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptx
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
 

More from Fulchand Kajale

Introduction to Biopharmaceutics and Pharmacokinetics
Introduction to Biopharmaceutics and PharmacokineticsIntroduction to Biopharmaceutics and Pharmacokinetics
Introduction to Biopharmaceutics and PharmacokineticsFulchand Kajale
 
Cardiovascular system
Cardiovascular systemCardiovascular system
Cardiovascular systemFulchand Kajale
 
Peripheral Nervous System
Peripheral Nervous SystemPeripheral Nervous System
Peripheral Nervous SystemFulchand Kajale
 
Body fluids and blood.pptx
Body fluids and blood.pptxBody fluids and blood.pptx
Body fluids and blood.pptxFulchand Kajale
 
Polymorphism affecting drug metabolism
Polymorphism affecting drug metabolism Polymorphism affecting drug metabolism
Polymorphism affecting drug metabolism Fulchand Kajale
 
Application of infrared spectroscopy
Application of infrared spectroscopyApplication of infrared spectroscopy
Application of infrared spectroscopyFulchand Kajale
 
Ionazation in Mass spectroscopy
Ionazation in Mass spectroscopy Ionazation in Mass spectroscopy
Ionazation in Mass spectroscopy Fulchand Kajale
 

More from Fulchand Kajale (9)

Introduction to Biopharmaceutics and Pharmacokinetics
Introduction to Biopharmaceutics and PharmacokineticsIntroduction to Biopharmaceutics and Pharmacokinetics
Introduction to Biopharmaceutics and Pharmacokinetics
 
Cardiovascular system
Cardiovascular systemCardiovascular system
Cardiovascular system
 
Peripheral Nervous System
Peripheral Nervous SystemPeripheral Nervous System
Peripheral Nervous System
 
Body fluids and blood.pptx
Body fluids and blood.pptxBody fluids and blood.pptx
Body fluids and blood.pptx
 
skeletal system
skeletal systemskeletal system
skeletal system
 
Polymorphism affecting drug metabolism
Polymorphism affecting drug metabolism Polymorphism affecting drug metabolism
Polymorphism affecting drug metabolism
 
Application of infrared spectroscopy
Application of infrared spectroscopyApplication of infrared spectroscopy
Application of infrared spectroscopy
 
Ionazation in Mass spectroscopy
Ionazation in Mass spectroscopy Ionazation in Mass spectroscopy
Ionazation in Mass spectroscopy
 
Biosensors
BiosensorsBiosensors
Biosensors
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 

Recently uploaded (20)

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 

vigiflow .pptx

  • 1. VIGIFLOW Presented by : Mr. Kajale Fulchand Vishwanath M.Pharm first year 2ñd semester Guided by: Ms. Shagufta Farooqui Assistant professor Department of Pharmacology Shri Sharda Bhavan Education Society’s Nanded Pharmacy College Nanded Presentation on
  • 2. Content • What is VigiFlow • History • Creating a new report • General reporting • Report information section • Study information tab • Advantages • Disadvantages • Reference 2 11-07-2022
  • 3. What is VigiFlow ? • VigiFlow is a web-based ICSR data management system • It is complete easy management system of ICSR (individual Case safety reporting ). • Vigiflow can be used by any authority or company as a database for report management and data analysis . • Vigiflow is not primarily tool of UMC (Uppsala monitoring center) but the data can be transferred to UMC. 3 10/22/2022
  • 4. HISTORY: • Vigiflow was initiated in the year 2001 when swiss medic required a new pharmacovigilant body. • Vigiflow was created with name ADR PLOT . • It was supported with primary reporting facility 7 regional centre in 4 languages. • The first reporting was done in year 2003 at Ghana. 4 10/22/2022
  • 5. CREATING A NEW REPORT: • Once we load to new report option there are two sub option. • Standard case: In standard case, cases with ADR , ADE , side effect , drug reaction or reaction due to possible drug administration etc. • Parent child case : A parent child case is filled when the child is suffering from an ADE / ADR due to medication taken by parent. 5 10/22/2022
  • 6. General reporting • General reporting can be done by regional centre it consists of various important section to be filled. • Sender’s information • In sender information various mandatory section like fillers name, address, designation, date, time and location. • Report information • This contain details about event. • Name/date of birth/age /age group, weight, gender 6 10/22/2022
  • 7. • Current/ Past drug therapy • This contain any drug treatment in the current or past time section must be Filled with details like • Drug name • Indication • Reaction observed • Reaction observed • Reaction list of code reaction causality assessment, onset of reaction end time of reaction , duration of reaction outcome of reaction details of any treatment given to counteract the reaction drug dose. 7 10/22/2022
  • 8. Drug consumed • List of drug as treatment for the reaction, Drug name dose • Assessment given • Assessment can be either be physically or Therapeutically • Overview of case • This is a free text which includes case narrative, Sender’s comments Sender’s diagnosis (MED DRA or ICD 10). International Classification of Diseases –Medical Dictionary for Regulatory Activities 8 10/22/2022
  • 9. Image.no 1 Reporting of adverse drug reactions in VigiFlow 9 10/22/2022
  • 10. Report information section Spontaneous: For adverse events collected from the spontaneous reporting system the report type Spontaneous report applies Study: For adverse event reports collected from studies Report from study applies 10 10/22/2022 Image no 2 Report information section
  • 11. Study Information Tab Study type: select as applicable (e.g. Clinical trials) Study name: enter as applicable according to study title (e.g. An international randomized trial of additional treatments for COVID- 19 in hospitalized patients who are all receiving the local standard of care) 11 10/22/2022 Image no 3 study information tab
  • 12. Adverse reaction section Reaction/event : Structure the Reaction/event using the appropriate MedDRA term. Use the +Sign to structure multiple reactions e.g. If Lack of therapeutic efficacy • Reaction/event as reported by initial reporter: enter the Reaction/event as described by the initial reporter. 12 10/22/2022 Image no 4 Adverse reaction section
  • 13. Suspected ingredient • It is possible to indicate which component of the medicinal product is the suspect of causing the events according to the following list • Active ingredient • Preservative • Antioxidant • Stabilizer • Colour • Flavouring agent • Solvent • Constituent • Excess percent 13 10/22/2022 Image no 5 suspected ingredients
  • 14. • Advantages • Free text providing complete data entry • Easy and constant connection between regional and national servers • Integrated dictionaries which helps correct coding . • Disadvantages • Server of different country might have glitch in uploading. • Need faster internet server. 14 10/22/2022
  • 15. Conclusions • VigiFlow is a web-based ICSR data management system that is used reporting of adverse drug reactions. • It is easy and constant connection between regional and national servers. 10/22/2022 15